Humana Inc.

HUM · NYSE

Humana reported 2025 revenue of $129.66 billion and Q1 2026 revenue of $39.65 billion. The thesis turns on whether Medicare Advantage scale can translate into durable margins and cash flow while medical cost trends, rate pressure and regulatory scrutiny remain central risks.

Follow Add to Watchlist Ask Question

NYSE HUM Coverage Bootstrap Humana Inc.

Latest ReportMay 20, 2026Humana: the Medicare giant has to prove margins can recoverView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Company filters1 of 1 reports match

Clear filters

Add tags

Selected tags

NYSE

Clear tags

Latest Thesis

Humana: the Medicare giant has to prove margins can recover

May 20, 2026Research reportSlides available

Read report Open slides Discussion (0)

Humana Inc.the Medicare giant has to prove margins can recoverMay 20, 2026

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Recent Reports

Compact report index for this company.

View all 1 reports ->

ReportTypeUpdatedReadActions

Humana: the Medicare giant has to prove margins can recoverHumana reported 2025 revenue of $129.66 billion and Q1 2026 revenue of $39.65 billion. The thesis turns on whether Medicare Advantage scale can translate into durable margins and cash flow while medical cost trends, rate pressure and regulatory scrutiny remain central risks.NYSEMay 20, 2026Research reportRead Slides